Placebo affects the performance of rats in models of depression: Is it a good control for behavioral experiments?

European Neuropsychopharmacology

Volumn 11, Issue 3, 2001, Pages 209-213

  Drago, F ^a   Nicolosi, A ^a   Micale, V ^a   Lo Menzo, G ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Clomipramine; Depression; Despair test; Models of depression; Placebo; Reserpine induced behavioral changes

Indexed keywords

CLOMIPRAMINE; PLACEBO; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; CLOMIPRAMINE; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PLACEBO EFFECT; RATS; RATS, WISTAR;

EID: 0034964155     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00084-0     Document Type: Article

References (18)

1. Evidence for increased effectiveness of placebos with increased stress
2. Clinical features of depressed patients who do and not improve with placebo
3. Placebo response in panic disorder
4. On the ethical acceptability of placebo application in neuropsychiatric research
5. Can the placebo be the cure?
6. The placebo response in pain reduction
7. Which depression responds to placebo?
8. Animal models and human depressive disorders
9. Are antidepressants better than placebo?
10. The placebo effect in agoraphobia
11. Patterns of response during placebo treatment of panic disorder
12. Active placebos in antipressant trials
13. Principles of therapeutics
14. Placebo effectiveness in psychiatric disorders: is it in part a dopamine-mediated effect? A hypothesis
15. Placebo controlled studies in depression: necessity and feasibility
16. The biology of placebo; implication of endogenous opioids
17. The validity of animal models of depression